AbstractUlcerative colitis (UC) has emerged as a global healthcare issue due to high prevalence and unsatisfying therapeutic measures. 20(S)‐ Protopanaxadiol saponins (PDS) from Panax notoginseng with anti‐inflammatory properties is a potential anti‐colitis agent. Herein, we explored the effects and mechanisms of PDS administration on experimental murine UC. Dextran sulfate sodium‐induced murine UC model was employed to investigate anti‐colitis effects of PDS, and associated mechanisms were further verified in HMGB1‐exposed THP‐1 macrophages. Results indicated that PDS administration exerted ameliorative effects against experimental UC. Moreover, PDS administration remarkably downregulated mRNA expressions and productions of related pro‐inflammatory mediators, and reversed elevated expressions of proteins related to NLRP3 inflammasome after colitis induction. Furthermore, administration with PDS also suppressed the expression and translocation of HMGB1, interrupting the downstream TLR4/NF‐κB pathway. In vitro, ginsenoside CK and 20(S)‐protopanaxadiol, the metabolites of PDS, exhibited greater potential in anti‐inflammation, and intervened with the TLR4‐binding domain of HMGB1 predictably. Expectedly, ginsenoside CK and 20(S)‐protopanaxadiol administrations inhibited the activation of TLR4/NF‐κB/NLRP3 inflammasome pathway in HMGB1‐exposed THP‐1 macrophages. Summarily, PDS administration attenuated inflammatory injury in experimental colitis by blocking the binding of HMGB1 to TLR4, majorly attributed to the antagonistic efficacies of ginsenoside CK and 20(S)‐protopanaxadiol.

More from our Archive

• DOI: 10.3390/vaccines11071217 2023

  Artificial Intelligence and Public Health: Evaluating ChatGPT Responses to Vaccination Myths and Misconceptions

  Giovanna Deiana, Marco Dettori, Antonella Arghittu, Antonio Azara, Giovanni Gabutti, Paolo Castiglia

• DOI: 10.1002/ptr.7937 2023

  Recent insights into the nutritional immunomodulation of cancer‐related <scp>microRNAs</scp>

  Teslime Özge Şahin, Birsen Yılmaz, Neslihan Yeşilyurt, Donatella Cicia, Anna Szymanowska, Paola Amero, Duygu Ağagündüz, Raffaele Capasso

• DOI: 10.1111/cns.14341 2023

  Evaluation of <scp>α‐synuclein</scp> in <scp>CNS</scp>‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis

  Hash Brown Taha, Shomik S. Ati

• DOI: 10.2174/1381612829666230707121415 2023

  Recent Update on Pharmacokinetics and Drug Metabolism in CNS-based Drug Discovery

  Sachin Nashik Sanap, Amol Chhatrapati Bisen, Ashwini Kedar, Sristi Agrawal, Rabi Sankar Bhatta

• DOI: 10.1111/cns.14333 2023

  Ultrasound reduces inflammation by modulating <scp>M1</scp>/<scp>M2</scp> polarization of microglia through <scp>STAT1</scp>/<scp>STAT6</scp>/<scp>PPARγ</scp> signaling pathways

  Chin‐Hung Hsu, Yi‐Ju Pan, Yin‐Ting Zheng, Raymond Y. Lo, Feng‐Yi Yang

• DOI: 10.3390/vaccines11071181 2023

  The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

  Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov, Tsvetelina Velikova

• DOI: 10.3390/vaccines11071177 2023

  COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India

  Nandini Sharma, Saurav Basu, Heena Lalwani, Shivani Rao, Mansi Malik, Sandeep Garg, Rahul Shrivastava, Mongjam Meghachandra Singh

• DOI: 10.1093/jac/dkad208 2023

  Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital <i>Mycoplasma genitalium</i> infections: a prospective cohort study

  Naokatsu Ando, Daisuke Mizushima, Misao Takano, Morika Mitobe, Kai Kobayashi, Hiroaki Kubota, Hirofumi Miyake, Jun Suzuki, Kenji Sadamasu, Takahiro Aoki, Koji Watanabe, Haruka Uemura, Yasuaki Yanagawa, Hiroyuki Gatanaga, Shinichi Oka

• DOI: 10.1093/jac/dkad216 2023

  Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients

  Mingyao Sun, Honghao Lai, Jiajie Huang, Jianing Liu, Ying Li, Jinhui Tian, Caiyun Zhang, Janne Estill, Zhigang Zhang, Long Ge

• DOI: 10.21272/mmi.2023.2-19 2023

  Effect of Education on Ease of Doing Business in Conditions of Innovation Development: Factor Analysis and Multiple Regression

  Anastasiia Samoilikova, Valeriia Herasymenko, Anzhela Kuznyetsova, Milos Tumpach, Martina Ballova, Larisa Savga